Investec Bank Plc has submitted a Form 8.5 public dealing disclosure relating to its trading activity in Advanced Medical Solutions Group Plc (AMS.L) ordinary shares.
The disclosure, filed under Rule 8.5 of the Takeover Code, identifies Investec as an exempt principal trader acting in a client-serving capacity with recognised intermediary status.
Investec holds a dual role in this matter, serving as both advisor and joint broker to Advanced Medical Solutions Group Plc during the relevant offer period.
The dealings reported in the disclosure were undertaken on 27th July 2026, with the formal disclosure itself dated 28th July 2026.
According to the filing, Investec purchased a total of 1,017,488 ordinary shares in Advanced Medical Solutions Group Plc during the dealing date in question.
The purchase price ranged from a low of 280 pence per unit to a high of 280.25 pence per unit across those transactions.
Investec also recorded sales of 1,017,488 ordinary shares on the same date, with prices ranging between 280 and 280.5 pence per unit.
The filing confirms there were no cash-settled derivative transactions, no stock-settled derivative transactions, and no other dealings such as subscriptions or conversions recorded in the disclosure.
Investec also confirmed that no indemnity arrangements, option agreements, or other formal or informal understandings existed that could represent an inducement to deal or refrain from dealing.
Similarly, the bank reported no agreements or understandings relating to voting rights or the future acquisition or disposal of any relevant securities linked to derivatives.
The contact named in the disclosure is Priyali Bhattacharjee, reachable via telephone for any queries related to the filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to ensure market transparency during offer periods.
